Sign up to save your podcasts
Or
Share The Lancet Neurology: November 16, 2010
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Lancet Neurology: November 16, 2010
Discussion of the RE-LY trial subgroup for the secondary prevention of stroke, and phase 2 results of gene therapy for Parkinson's disease.
View all episodes
By The Lancet NeurologyDiscussion of the RE-LY trial subgroup for the secondary prevention of stroke, and phase 2 results of gene therapy for Parkinson's disease.
More shows like In conversation with...
View all
Neurology® Podcast
288 Listeners
Practical Neurology Podcast
44 Listeners
Hidden Brain
43,465 Listeners
Learning English Vocabulary
495 Listeners
The Daily
111,862 Listeners
JAMA Medical News
87 Listeners
The Clinical Problem Solvers
515 Listeners
Neurology Exam Prep Podcast
182 Listeners
eanCast: Weekly Neurology
0 Listeners
NEJM AI Grand Rounds
54 Listeners
Continuum Audio
78 Listeners